Berlin – September 11, 2026 -- Germany's federal government has proposed a 2027 budget with total expenditures of €555 billion, including a record €118 billion in investment spending, as parliamentary budget deliberations began this week with the bill's first reading in the Bundestag.

London – September 11, 2026 -- Brightstar Lottery PLC (NYSE: BRSL) launched a tender offer for any and all Regulation S interests in its outstanding €500,000,000 2.375% Senior Secured Notes due 2028, offering holders €990.00 per €1,000 in nominal value plus accrued interest.

Wiesbaden – September 11, 2026 -- German exports declined 0.8% month-on-month in July 2026 to a calendar- and seasonally-adjusted €138.2 billion, while imports dropped sharply by 5.7% to €116.9 billion, according to preliminary data from the Federal Statistical Office (Destatis).

The trade surplus widened to €21.3 billion in July, up from €15.4 billion in June, though below the €16.8 billion recorded in July 2025. Year-on-year, exports rose 6.1% and imports climbed 3.0% compared with July 2025.

Frankfurt – September 10, 2026 -- The German agricultural industry association IVA has dismissed a new study by the Pesticide Action Network (PAN) claiming more than 400 million pesticide-related poisoning cases occur globally each year, calling the figure scientifically indefensible.

Berlin – September 09, 2026 -- The TÜV Association has warned that the AfD's strong showing in the Saxony-Anhalt state election threatens Germany's evidence-based approach to climate, energy and digital policy.

Raamsdonksveer, Netherlands – September 09, 2026 -- Dutch company PAL-V has obtained European Production Organisation Approval (POA), becoming the first company in the FlyDrive segment of Advanced Air Mobility to hold both automotive and aviation production approvals for industrial-scale manufacturing.

Frankfurt am Main – September 09, 2026 -- Thirty percent of German small and mid-sized companies (Mittelstand) with foreign business expect their cross-border revenues to decline over the next three years, according to a new KfW Research study, with 6 percent forecasting a sharp drop. Roughly 24 percent anticipate growth, while 47 percent expect no change.

The findings stem from a January 2026 survey conducted before the outbreak of the Iran conflict, meaning sentiment may have since deteriorated further.

Beijing/Florence – September 08, 2026 -- Gan & Lee Pharmaceuticals (603087.SH) has signed an exclusive licensing agreement with Italy's The Menarini Group for its GLP-1 receptor agonist bofanglutide, a deal worth up to €726 million excluding royalties.

Beijing/Florence – September 08, 2026 -- Gan & Lee Pharmaceuticals (603087.SH) has signed an exclusive license agreement with Italy's Menarini Group worth up to €726 million, excluding royalties, to develop and commercialize the obesity drug bofanglutida across 39 European markets.

Beijing – September 08, 2026 -- Gan & Lee Pharmaceuticals (603087.SH) has signed an exclusive license agreement with Italy's Menarini Group worth up to EUR 726 million, excluding royalties, to register and commercialize its GLP-1 receptor agonist bofanglutide for obesity and overweight treatment across 39 countries.